257 related articles for article (PubMed ID: 19690584)
1. Impairment of glycosaminoglycan synthesis in mucopolysaccharidosis type IIIA cells by using siRNA: a potential therapeutic approach for Sanfilippo disease.
Dziedzic D; Wegrzyn G; Jakóbkiewicz-Banecka J
Eur J Hum Genet; 2010 Feb; 18(2):200-5. PubMed ID: 19690584
[TBL] [Abstract][Full Text] [Related]
2. Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses.
Kloska A; Jakóbkiewicz-Banecka J; Narajczyk M; Banecka-Majkutewicz Z; Węgrzyn G
Metab Brain Dis; 2011 Mar; 26(1):1-8. PubMed ID: 21305347
[TBL] [Abstract][Full Text] [Related]
3. Comparison of siRNA-mediated silencing of glycosaminoglycan synthesis genes and enzyme replacement therapy for mucopolysaccharidosis in cell culture studies.
Chmielarz I; Gabig-Cimińska M; Malinowska M; Banecka-Majkutewicz Z; Węgrzyn A; Jakobkiewicz-Banecka J
Acta Biochim Pol; 2012; 59(4):697-702. PubMed ID: 23251908
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of glycosaminoglycan synthesis using rhodamine B in a mouse model of mucopolysaccharidosis type IIIA.
Roberts AL; Thomas BJ; Wilkinson AS; Fletcher JM; Byers S
Pediatr Res; 2006 Sep; 60(3):309-14. PubMed ID: 16857766
[TBL] [Abstract][Full Text] [Related]
5. EXTL2 and EXTL3 inhibition with siRNAs as a promising substrate reduction therapy for Sanfilippo C syndrome.
Canals I; Benetó N; Cozar M; Vilageliu L; Grinberg D
Sci Rep; 2015 Sep; 5():13654. PubMed ID: 26347037
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous siRNA-mediated silencing of pairs of genes coding for enzymes involved in glycosaminoglycan synthesis.
Dziedzic D; Narajczyk M; Gabig-Cimińska M; Jakóbkiewicz-Banecka J
Acta Biochim Pol; 2012; 59(2):293-8. PubMed ID: 22590693
[TBL] [Abstract][Full Text] [Related]
7. Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses.
Piotrowska E; Jakóbkiewicz-Banecka J; Barańska S; Tylki-Szymańska A; Czartoryska B; Wegrzyn A; Wegrzyn G
Eur J Hum Genet; 2006 Jul; 14(7):846-52. PubMed ID: 16670689
[TBL] [Abstract][Full Text] [Related]
8. Genistin-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome: An open-label, pilot study in 10 pediatric patients.
Piotrowska E; Jakóbkiewicz-Banecka J; Tylki-Szymanska A; Liberek A; Maryniak A; Malinowska M; Czartoryska B; Puk E; Kloska A; Liberek T; Baranska S; Wegrzyn A; Wegrzyn G
Curr Ther Res Clin Exp; 2008 Apr; 69(2):166-79. PubMed ID: 24692796
[TBL] [Abstract][Full Text] [Related]
9. Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway.
Jakóbkiewicz-Banecka J; Piotrowska E; Narajczyk M; Barańska S; Wegrzyn G
J Biomed Sci; 2009 Mar; 16(1):26. PubMed ID: 19272193
[TBL] [Abstract][Full Text] [Related]
10. Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier.
Maccari F; Sorrentino NC; Mantovani V; Galeotti F; Fraldi A; Volpi N
Metab Brain Dis; 2017 Feb; 32(1):203-210. PubMed ID: 27585464
[TBL] [Abstract][Full Text] [Related]
11. UV irradiation-induced production of monoglycosylated biglycan through downregulation of xylosyltransferase 1 in cultured human dermal fibroblasts.
Jin CL; Oh JH; Han M; Shin MK; Yao C; Park CH; Jin ZH; Chung JH
J Dermatol Sci; 2015 Jul; 79(1):20-9. PubMed ID: 25936869
[TBL] [Abstract][Full Text] [Related]
12. High and prolonged sulfamidase secretion by the liver of MPS-IIIA mice following hydrodynamic tail vein delivery of antibiotic-free pFAR4 plasmid vector.
Quiviger M; Arfi A; Mansard D; Delacotte L; Pastor M; Scherman D; Marie C
Gene Ther; 2014 Dec; 21(12):1001-7. PubMed ID: 25142140
[TBL] [Abstract][Full Text] [Related]
13. Glycosaminoglycans and mucopolysaccharidosis type III.
Jakobkiewicz-Banecka J; Gabig-Ciminska M; Kloska A; Malinowska M; Piotrowska E; Banecka-Majkutewicz Z; Banecki B; Wegrzyn A; Wegrzyn G
Front Biosci (Landmark Ed); 2016 Jun; 21(7):1393-409. PubMed ID: 27100513
[TBL] [Abstract][Full Text] [Related]
14. Putative biological mechanisms of efficiency of substrate reduction therapies for mucopolysaccharidoses.
Banecka-Majkutewicz Z; Jakóbkiewicz-Banecka J; Gabig-Cimińska M; Węgrzyn A; Węgrzyn G
Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):461-8. PubMed ID: 22949095
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of brain pathology in heparan sulphate storing mucopolysaccharidoses.
Derrick-Roberts A; Kaidonis X; Jackson MR; Liaw WC; Ding X; Ong C; Ranieri E; Sharp P; Fletcher J; Byers S
Mol Genet Metab; 2020; 131(1-2):197-205. PubMed ID: 32739280
[TBL] [Abstract][Full Text] [Related]
16. Differences in gene expression patterns, revealed by RNA-seq analysis, between various Sanfilippo and Morquio disease subtypes.
Wiśniewska K; Gaffke L; Krzelowska K; Węgrzyn G; Pierzynowska K
Gene; 2022 Feb; 812():146090. PubMed ID: 34896230
[TBL] [Abstract][Full Text] [Related]
17. Mucopolysaccharidosis type III (Sanfilippo Syndrome): emerging treatment strategies.
de Ruijter J; Valstar MJ; Wijburg FA
Curr Pharm Biotechnol; 2011 Jun; 12(6):923-30. PubMed ID: 21235449
[TBL] [Abstract][Full Text] [Related]
18. A model of mucopolysaccharidosis IIIB (Sanfilippo syndrome type IIIB): N-acetyl-alpha-D-glucosaminidase deficiency in Schipperke dogs.
Ellinwood NM; Wang P; Skeen T; Sharp NJ; Cesta M; Decker S; Edwards NJ; Bublot I; Thompson JN; Bush W; Hardam E; Haskins ME; Giger U
J Inherit Metab Dis; 2003; 26(5):489-504. PubMed ID: 14518829
[TBL] [Abstract][Full Text] [Related]
19. Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome.
Scott HS; Blanch L; Guo XH; Freeman C; Orsborn A; Baker E; Sutherland GR; Morris CP; Hopwood JJ
Nat Genet; 1995 Dec; 11(4):465-7. PubMed ID: 7493035
[TBL] [Abstract][Full Text] [Related]
20. Improvement in behaviour after substrate deprivation therapy with rhodamine B in a mouse model of MPS IIIA.
Roberts AL; Rees MH; Klebe S; Fletcher JM; Byers S
Mol Genet Metab; 2007; 92(1-2):115-21. PubMed ID: 17681480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
